Across CCLE and GDSC cell-line panels, response to Cetuximab is significantly associated with the protein-level pathway activity of multiple pathways, with BREAST cell lines showing a particularly strong set of associations.
The most reproducible Cetuximab response-associated pathways across cancer lineages are Negative regulation of secretion by cell, DNA damage response, signal transduction by p53 class mediator, and Monoatomic anion homeostasis, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Cetuximab response versus Negative regulation of secretion by cell protein-level pathway activity in BREAST (Pearson r = -0.32).